세계의 바이오의약품 부형제 시장 보고서(2025년)

Biopharmaceutical excipients are inactive components combined with active pharmaceutical ingredients to support the development, stability, and delivery of biologic drugs. They improve the effectiveness, safety, and shelf-life of biopharmaceutical products without providing any therapeutic action themselves. These excipients consist of various substances such as sugars, polymers, and proteins that assist in drug formulation and administration.

The key product types of biopharmaceutical excipients include binders, coatings, diluents, disintegrants, lubricants and glidants, polyols, preservatives, solubilizers and surfactants or emulsifiers, and suspending and viscosity agents. Binders are materials added to powders or granules in pharmaceutical, food, or material formulations to keep ingredients together, ensuring cohesion and structural integrity in the final product. The different types of biologics include antibodies, vaccines, cell therapies, and others. Their multiple functionalities consist of fillers and diluents, binders, suspending and viscosity agents, flavoring agents and sweeteners, coating agents, colorants, disintegrants, lubricants and glidants, and preservatives. The various applications include injectable formulations, oral formulations, topical formulations, transdermal formulations, and cell and gene therapies, and they are used by several end users such as biopharmaceutical and pharmaceutical companies, contract manufacturers, and research institutes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The biopharmaceutical excipients market research report is one of a series of new reports from The Business Research Company that provides biopharmaceutical excipients market statistics, including the biopharmaceutical excipients industry global market size, regional shares, competitors with the biopharmaceutical excipients market share, detailed biopharmaceutical excipients market segments, market trends, and opportunities, and any further data you may need to thrive in the biopharmaceutical excipients industry. This biopharmaceutical excipients market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biopharmaceutical excipients market size has grown strongly in recent years. It will grow from $2.99 billion in 2024 to $3.27 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be linked to increasing demand for biologics, growing prevalence of chronic diseases, rising focus on controlled drug delivery, expansion of biopharmaceutical manufacturing capacity, and increasing regulatory approvals for biologics.

The biopharmaceutical excipients market size is expected to see strong growth in the next few years. It will grow to $4.63 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be driven by growing investment in biopharmaceutical research, rising adoption of personalized medicine, increasing outsourcing to contract manufacturing organizations, expansion of global cold chain infrastructure, and growing focus on advanced formulation development. Major trends in the forecast period include advancements in excipient compatibility testing, innovations in drug delivery technologies, developments in sustainable excipient manufacturing, research and development in novel stabilizers, and advancements in analytical characterization methods.

The increasing demand for vaccine development is expected to drive the growth of the biopharmaceutical excipients market. Vaccine development involves creating and formulating immunizations to prevent infectious diseases and improve public health. High-quality excipients are essential in ensuring the stability, efficacy, and safety of vaccines. The rising demand for vaccines is driven by global efforts to prevent infectious diseases, strengthen public health systems, and accelerate research for faster, more effective immunization solutions. Biopharmaceutical excipients play a critical role in vaccine formulations by stabilizing antigens, enhancing solubility, and maintaining integrity during storage and distribution. For example, in 2025, the Centers for Disease Control and Prevention (CDC) reported that adolescent vaccination coverage for key vaccines, such as tetanus, diphtheria, and acellular pertussis, increased from 89.9% in 2022 to 91.3% in 2024. Coverage for the meningococcal conjugate vaccine rose from 88.6% to 90.1%, and human papillomavirus vaccine coverage grew significantly from 76.0% to 92.6% over the same period. This surge in immunization coverage is driving the demand for vaccine development and, consequently, the growth of the biopharmaceutical excipients market.

Companies in the biopharmaceutical excipients market are focusing on technological innovations, such as ultra-high purity surfactants, to improve protein stability, prevent degradation, and support regulatory compliance in injectable formulations. These surfactants are specially refined surface-active agents with minimal impurities and consistent composition, ensuring stability, safety, and performance in sensitive biopharmaceutical formulations. For example, in September 2025, Evonik Industries AG, a Germany-based chemicals company, launched MaxiPure Polysorbate 80 for injectable and biopharmaceutical applications. This excipient is engineered with over 98% oleic acid content, exceptional clarity, and full compliance with the European Pharmacopoeia, United States Pharmacopoeia, Japanese Pharmacopoeia, and Chinese Pharmacopoeia standards. It addresses challenges in protein stability, prevents oxidative degradation, enables consistent solubilization of hydrophobic active ingredients, and enhances formulation reliability. By integrating this excipient, Evonik helps pharmaceutical companies develop complex biologics and injectable therapies more efficiently while ensuring safety and regulatory compliance.

In May 2025, Roquette Freres, a France-based provider of pharmaceutical excipients, acquired International Flavors & Fragrances (IFF) Pharma Solutions for an undisclosed amount. This acquisition strengthens Roquette's portfolio of pharmaceutical excipients by integrating IFF Pharma Solutions' expertise and innovative products. The move enhances Roquette's ability to deliver high-value drug delivery solutions and support the development of advanced pharmaceutical formulations worldwide. IFF Pharma Solutions, a U.S.-based company, specializes in pharmaceutical excipients and functional ingredients that aid in drug formulation and delivery within the biopharmaceutical industry.

Major companies operating in the biopharmaceutical excipients market are The Archer-Daniels-Midland Company, BASF SE, The Dow Chemical Company, Mitsubishi Chemical Group Corporation, Novo Nordisk A/S, Associated British Foods plc, Merck KGaA, Asahi Kasei Corporation, Evonik Industries AG, Kerry Group plc, Wacker Chemie AG, Clariant AG, Shin-Etsu Chemical Co. Ltd., Roquette Freres, IMCD Group N.V., Croda International Plc, Ashland Global Holdings Inc., NOF Corporation, Colorcon Limited, J. Rettenmaier & Sohne GmbH + Co. KG, Spectrum Chemical Manufacturing Corporation, BioSpectra Inc., Sigachi Industries Limited, DFE Pharma, FUJIFILM Toyama Chemical Co. Ltd, Kirsch Pharma GmbH, Meggle Group GmbH, InVitria Inc., BOC Sciences Inc.

North America was the largest region in the biopharmaceutical excipients market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in biopharmaceutical excipients report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the biopharmaceutical excipients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biopharmaceutical excipients market consists of sales of growth media, buffer solutions, stabilizers, cryoprotectants, preservatives, surfactants, salts, amino acids, sugars. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biopharmaceutical Excipients Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biopharmaceutical excipients market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biopharmaceutical excipients ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biopharmaceutical excipients market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Types: Binders; Coatings; Diluents; Disintegrants; Lubricants And Glidants; Polyols; Preservatives; Solubilizers And Surfactants Or Emulsifiers; Suspending And Viscosity Agents
• 2) By Type Of Biologics: Antibodies; Vaccines; Cell Therapies; Other Biologics
• 3) By Functionality: Fillers And Diluents; Binders; Suspending And Viscosity Agents; Flavouring Agents And Sweeteners; Coating Agents; Colourants; Disintegrants; Lubricants And Glidants; Preservatives
• 4) By Application: Injectable Formulations; Oral Formulations; Topical Formulations; Transdermal Formulations; Cell and Gene Therapy
• 5) By End Users: Biopharmaceutical Companies And Pharmaceutical Companies; Contract Manufacturers; Research Institutes
• Subsegments:
• 1) By Binders: Starch Binders; Cellulose Binders; Synthetic Binders; Natural Polymer Binders
• 2) By Coatings: Film Coatings; Sugar Coatings; Enteric Coatings; Polymer Coatings
• 3) By Diluents: Lactose; Microcrystalline Cellulose; Starch; Mannitol
• 4) By Disintegrants: Crosslinked Cellulose; Starch Derivatives; Crospovidone; Sodium Starch Glycolate
• 5) By Lubricants And Glidants: Magnesium Stearate; Stearic Acid; Talc; Silicon Dioxide
• 6) By Polyols: Sorbitol; Mannitol; Glycerol; Xylitol
• 7) By Preservatives: Parabens; Benzoates; Sorbates; Phenols
• 8) By Solubilizers And Surfactants Or Emulsifiers: Polysorbates; Polyethylene Glycol; Lecithin; Sodium Lauryl Sulfate
• 9) By Suspending And Viscosity Agents: Cellulose Derivatives; Xanthan Gum; Guar Gum; Carbomers
• Companies Mentioned: The Archer-Daniels-Midland Company; BASF SE; The Dow Chemical Company; Mitsubishi Chemical Group Corporation; Novo Nordisk A/S; Associated British Foods plc; Merck KGaA; Asahi Kasei Corporation; Evonik Industries AG; Kerry Group plc; Wacker Chemie AG; Clariant AG; Shin-Etsu Chemical Co. Ltd.; Roquette Freres; IMCD Group N.V.; Croda International Plc; Ashland Global Holdings Inc.; NOF Corporation; Colorcon Limited; J. Rettenmaier & Sohne GmbH + Co. KG; Spectrum Chemical Manufacturing Corporation; BioSpectra Inc.; Sigachi Industries Limited; DFE Pharma; FUJIFILM Toyama Chemical Co. Ltd; Kirsch Pharma GmbH; Meggle Group GmbH; InVitria Inc.; BOC Sciences Inc.
• Countries:

Table of Contents

1. Executive Summary

2. Biopharmaceutical Excipients Market Characteristics

3. Biopharmaceutical Excipients Market Trends And Strategies

4. Biopharmaceutical Excipients Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Biopharmaceutical Excipients Growth Analysis And Strategic Analysis Framework

• 5.1. Global Biopharmaceutical Excipients PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Biopharmaceutical Excipients Market Growth Rate Analysis
• 5.4. Global Biopharmaceutical Excipients Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Biopharmaceutical Excipients Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Biopharmaceutical Excipients Total Addressable Market (TAM)

6. Biopharmaceutical Excipients Market Segmentation

• 6.1. Global Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Binders
• Coatings
• Diluents
• Disintegrants
• Lubricants And Glidants
• Polyols
• Preservatives
• Solubilizers And Surfactants Or Emulsifiers
• Suspending And Viscosity Agents
• 6.2. Global Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibodies
• Vaccines
• Cell Therapies
• Other Biologics
• 6.3. Global Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fillers And Diluents
• Binders
• Suspending And Viscosity Agents
• Flavouring Agents And Sweeteners
• Coating Agents
• Colourants
• Disintegrants
• Lubricants And Glidants
• Preservatives
• 6.4. Global Biopharmaceutical Excipients Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Formulations
• Oral Formulations
• Topical Formulations
• Transdermal Formulations
• Cell and Gene Therapy
• 6.5. Global Biopharmaceutical Excipients Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biopharmaceutical Companies And Pharmaceutical Companies
• Contract Manufacturers
• Research Institutes
• 6.6. Global Biopharmaceutical Excipients Market, Sub-Segmentation Of Binders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Starch Binders
• Cellulose Binders
• Synthetic Binders
• Natural Polymer Binders
• 6.7. Global Biopharmaceutical Excipients Market, Sub-Segmentation Of Coatings, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Film Coatings
• Sugar Coatings
• Enteric Coatings
• Polymer Coatings
• 6.8. Global Biopharmaceutical Excipients Market, Sub-Segmentation Of Diluents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lactose
• Microcrystalline Cellulose
• Starch
• Mannitol
• 6.9. Global Biopharmaceutical Excipients Market, Sub-Segmentation Of Disintegrants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Crosslinked Cellulose
• Starch Derivatives
• Crospovidone
• Sodium Starch Glycolate
• 6.10. Global Biopharmaceutical Excipients Market, Sub-Segmentation Of Lubricants And Glidants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Magnesium Stearate
• Stearic Acid
• Talc
• Silicon Dioxide
• 6.11. Global Biopharmaceutical Excipients Market, Sub-Segmentation Of Polyols, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sorbitol
• Mannitol
• Glycerol
• Xylitol
• 6.12. Global Biopharmaceutical Excipients Market, Sub-Segmentation Of Preservatives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Parabens
• Benzoates
• Sorbates
• Phenols
• 6.13. Global Biopharmaceutical Excipients Market, Sub-Segmentation Of Solubilizers And Surfactants Or Emulsifiers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polysorbates
• Polyethylene Glycol
• Lecithin
• Sodium Lauryl Sulfate
• 6.14. Global Biopharmaceutical Excipients Market, Sub-Segmentation Of Suspending And Viscosity Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cellulose Derivatives
• Xanthan Gum
• Guar Gum
• Carbomers

7. Biopharmaceutical Excipients Market Regional And Country Analysis

• 7.1. Global Biopharmaceutical Excipients Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Biopharmaceutical Excipients Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biopharmaceutical Excipients Market

• 8.1. Asia-Pacific Biopharmaceutical Excipients Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biopharmaceutical Excipients Market

• 9.1. China Biopharmaceutical Excipients Market Overview
• 9.2. China Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biopharmaceutical Excipients Market

• 10.1. India Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biopharmaceutical Excipients Market

• 11.1. Japan Biopharmaceutical Excipients Market Overview
• 11.2. Japan Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biopharmaceutical Excipients Market

• 12.1. Australia Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biopharmaceutical Excipients Market

• 13.1. Indonesia Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biopharmaceutical Excipients Market

• 14.1. South Korea Biopharmaceutical Excipients Market Overview
• 14.2. South Korea Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biopharmaceutical Excipients Market

• 15.1. Western Europe Biopharmaceutical Excipients Market Overview
• 15.2. Western Europe Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biopharmaceutical Excipients Market

• 16.1. UK Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biopharmaceutical Excipients Market

• 17.1. Germany Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biopharmaceutical Excipients Market

• 18.1. France Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biopharmaceutical Excipients Market

• 19.1. Italy Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biopharmaceutical Excipients Market

• 20.1. Spain Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biopharmaceutical Excipients Market

• 21.1. Eastern Europe Biopharmaceutical Excipients Market Overview
• 21.2. Eastern Europe Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biopharmaceutical Excipients Market

• 22.1. Russia Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biopharmaceutical Excipients Market

• 23.1. North America Biopharmaceutical Excipients Market Overview
• 23.2. North America Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biopharmaceutical Excipients Market

• 24.1. USA Biopharmaceutical Excipients Market Overview
• 24.2. USA Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biopharmaceutical Excipients Market

• 25.1. Canada Biopharmaceutical Excipients Market Overview
• 25.2. Canada Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biopharmaceutical Excipients Market

• 26.1. South America Biopharmaceutical Excipients Market Overview
• 26.2. South America Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biopharmaceutical Excipients Market

• 27.1. Brazil Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biopharmaceutical Excipients Market

• 28.1. Middle East Biopharmaceutical Excipients Market Overview
• 28.2. Middle East Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biopharmaceutical Excipients Market

• 29.1. Africa Biopharmaceutical Excipients Market Overview
• 29.2. Africa Biopharmaceutical Excipients Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Biopharmaceutical Excipients Market, Segmentation By Type Of Biologics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Biopharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biopharmaceutical Excipients Market Competitive Landscape And Company Profiles

• 30.1. Biopharmaceutical Excipients Market Competitive Landscape
• 30.2. Biopharmaceutical Excipients Market Company Profiles
  • 30.2.1. The Archer-Daniels-Midland Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. BASF SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. The Dow Chemical Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Mitsubishi Chemical Group Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis

31. Biopharmaceutical Excipients Market Other Major And Innovative Companies

• 31.1. Associated British Foods plc
• 31.2. Merck KGaA
• 31.3. Asahi Kasei Corporation
• 31.4. Evonik Industries AG
• 31.5. Kerry Group plc
• 31.6. Wacker Chemie AG
• 31.7. Clariant AG
• 31.8. Shin-Etsu Chemical Co. Ltd.
• 31.9. Roquette Freres
• 31.10. IMCD Group N.V.
• 31.11. Croda International Plc
• 31.12. Ashland Global Holdings Inc.
• 31.13. NOF Corporation
• 31.14. Colorcon Limited
• 31.15. J. Rettenmaier & Sohne GmbH + Co. KG

32. Global Biopharmaceutical Excipients Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biopharmaceutical Excipients Market

34. Recent Developments In The Biopharmaceutical Excipients Market

35. Biopharmaceutical Excipients Market High Potential Countries, Segments and Strategies

• 35.1 Biopharmaceutical Excipients Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Biopharmaceutical Excipients Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Biopharmaceutical Excipients Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer